These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 18498131)

  • 1. Aberrant expression of Cks1 and Cks2 contributes to prostate tumorigenesis by promoting proliferation and inhibiting programmed cell death.
    Lan Y; Zhang Y; Wang J; Lin C; Ittmann MM; Wang F
    Int J Cancer; 2008 Aug; 123(3):543-51. PubMed ID: 18498131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin-dependent kinase-associated proteins Cks1 and Cks2 are essential during early embryogenesis and for cell cycle progression in somatic cells.
    Martinsson-Ahlzén HS; Liberal V; Grünenfelder B; Chaves SR; Spruck CH; Reed SI
    Mol Cell Biol; 2008 Sep; 28(18):5698-709. PubMed ID: 18625720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of overexpressed cyclin-dependent kinase subunits 1 and 2 in esophageal carcinoma.
    Wang JJ; Fang ZX; Ye HM; You P; Cai MJ; Duan HB; Wang F; Zhang ZY
    Dis Esophagus; 2013; 26(7):729-36. PubMed ID: 23301842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance and expression of cyclin kinase subunits 1 and 2 in hepatocellular carcinoma.
    Shen DY; Fang ZX; You P; Liu PG; Wang F; Huang CL; Yao XB; Chen ZX; Zhang ZY
    Liver Int; 2010 Jan; 30(1):119-25. PubMed ID: 19845855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CDK subunit CKS2 counteracts CKS1 to control cyclin A/CDK2 activity in maintaining replicative fidelity and neurodevelopment.
    Frontini M; Kukalev A; Leo E; Ng YM; Cervantes M; Cheng CW; Holic R; Dormann D; Tse E; Pommier Y; Yu V
    Dev Cell; 2012 Aug; 23(2):356-70. PubMed ID: 22898779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CKS1 Germ Line Exclusion Is Essential for the Transition from Meiosis to Early Embryonic Development.
    Ellederova Z; Del Rincon S; Koncicka M; Susor A; Kubelka M; Sun D; Spruck C
    Mol Cell Biol; 2019 Jul; 39(13):. PubMed ID: 30988159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic potential of cyclin kinase subunit-2 in cholangiocarcinoma.
    Shen DY; Zhan YH; Wang QM; Rui G; Zhang ZM
    Liver Int; 2013 Jan; 33(1):137-48. PubMed ID: 23121546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin-dependent kinase subunit2 (CKS2) promotes malignant phenotypes and epithelial-mesenchymal transition-like process in glioma by activating TGFβ/SMAD signaling.
    Feng F; Zhao Z; Cai X; Heng X; Ma X
    Cancer Med; 2023 Mar; 12(5):5889-5907. PubMed ID: 36284444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological and biological significance of CDC28 protein kinase regulatory subunit 2 overexpression in human gastric cancer.
    Tanaka F; Matsuzaki S; Mimori K; Kita Y; Inoue H; Mori M
    Int J Oncol; 2011 Aug; 39(2):361-72. PubMed ID: 21617860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depletion of Cks1 and Cks2 expression compromises cell proliferation and enhance chemotherapy-induced apoptosis in HepG2 cells.
    Lin L; Fang Z; Lin H; You H; Wang J; Su Y; Wang F; Zhang ZY
    Oncol Rep; 2016 Jan; 35(1):26-32. PubMed ID: 26531156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CKS2 promotes tumor progression and metastasis and is an independent predictor of poor prognosis in epithelial ovarian cancer.
    Xu JH; Wang Y; Xu D
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3225-3234. PubMed ID: 31081074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of the cycline kinase subunit CKS2 increases cell proliferation rate in gastric cancer.
    Kang MA; Kim JT; Kim JH; Kim SY; Kim YH; Yeom YI; Lee Y; Lee HG
    J Cancer Res Clin Oncol; 2009 Jun; 135(6):761-9. PubMed ID: 19034516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CKS2 Promotes the Growth in Non-Small-Cell Lung Cancer by Downregulating Cyclin-Dependent Kinase Inhibitor.
    Wan Z; Wang L; Yang D; Li P; Liu Q; Wang B
    Pathobiology; 2022; 89(1):13-22. PubMed ID: 34333494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Cks1/Cks2 axis fine-tunes Mll1 expression and is crucial for MLL-rearranged leukaemia cell viability.
    Grey W; Ivey A; Milne TA; Haferlach T; Grimwade D; Uhlmann F; Voisset E; Yu V
    Biochim Biophys Acta Mol Cell Res; 2018 Jan; 1865(1):105-116. PubMed ID: 28939057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of CKS2 is associated with a poor prognosis and promotes cell proliferation and invasion in breast cancer.
    Huang N; Wu Z; Hong H; Wang X; Yang F; Li H
    Mol Med Rep; 2019 Jun; 19(6):4761-4769. PubMed ID: 30957190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA silencing of Cks1 induced G2/M arrest and apoptosis in human lung cancer cells.
    Tsai YS; Chang HC; Chuang LY; Hung WC
    IUBMB Life; 2005 Aug; 57(8):583-9. PubMed ID: 16118116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CKS proteins protect mitochondrial genome integrity by interacting with mitochondrial single-stranded DNA-binding protein.
    Radulovic M; Crane E; Crawford M; Godovac-Zimmermann J; Yu VP
    Mol Cell Proteomics; 2010 Jan; 9(1):145-52. PubMed ID: 19786724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-26a and its target CKS2 modulate cell growth and tumorigenesis of papillary thyroid carcinoma.
    Lv M; Zhang X; Li M; Chen Q; Ye M; Liang W; Ding L; Cai H; Fu D; Lv Z
    PLoS One; 2013; 8(7):e67591. PubMed ID: 23861775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Cks1 overexpression in oral squamous cell carcinomas: cooperation with Skp2 in promoting p27 degradation.
    Kitajima S; Kudo Y; Ogawa I; Bashir T; Kitagawa M; Miyauchi M; Pagano M; Takata T
    Am J Pathol; 2004 Dec; 165(6):2147-55. PubMed ID: 15579456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of Cks1 is associated with poor survival by inhibiting apoptosis in breast cancer.
    Wang XC; Tian LL; Tian J; Wu HL; Meng AM
    J Cancer Res Clin Oncol; 2009 Oct; 135(10):1393-401. PubMed ID: 19352700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.